...
首页> 外文期刊>AIDS care. >Cost and cost threshold analyses for 12 innovative US HIV linkage and retention in care programs
【24h】

Cost and cost threshold analyses for 12 innovative US HIV linkage and retention in care programs

机译:成本和成本阈值分析,用于12种美国创新性HIV关联和护理计划

获取原文
获取原文并翻译 | 示例
           

摘要

Out of >1,000,000 people living with HIV in the USA, an estimated 60% were not adequately engaged in medical care in 2011. In response, AIDS United spearheaded 12 HIV linkage and retention in care programs. These programs were supported by the Social Innovation Fund, a White House initiative. Each program reflected the needs of its local population living with HIV. Economic analyses of such programs, such as cost and cost threshold analyses, provide important information for policy-makers and others allocating resources or planning programs. Implementation costs were examined from societal and payer perspectives. This paper presents the results of cost threshold analyses, which provide an estimated number of HIV transmissions that would have to be averted for each program to be considered cost-saving and cost-effective. The methods were adapted from the US Panel on Cost-effectiveness in Health and Medicine. Per client program costs ranged from $1109.45 to $7602.54 from a societal perspective. The cost-saving thresholds ranged from 0.32 to 1.19 infections averted, and the cost-effectiveness thresholds ranged from 0.11 to 0.43 infections averted by the programs. These results suggest that such programs are a sound and efficient investment towards supporting goals set by US HIV policy-makers. Cost-utility data are pending.
机译:2011年,在美国超过1,000,000的HIV感染者中,估计有60%的人没有充分从事医疗服务。作为回应,AIDS United率先领导了12个HIV联系并将其保留在护理计划中。这些计划得到了白宫倡议社会创新基金的支持。每个方案都反映了当地艾滋病毒携带者的需求。对此类计划的经济分析,例如成本和成本阈值分析,为决策者和其他分配资源或计划计划的人提供了重要信息。从社会和付款方的角度审查了实施成本。本文介绍了成本阈值分析的结果,这些结果提供了估计的艾滋病毒传播数量,对于每个计划而言,要想节省成本和节省成本,就必须避免这种传播。该方法改编自美国健康和医学成本效益专家小组。从社会角度来看,每个客户计划的费用从1109.45美元到7602.54美元不等。程序避免的成本节省阈值范围是从0.32到1.19感染,成本效益的阈值范围是0.11到0.43。这些结果表明,此类计划是对支持美国HIV决策者设定的目标的一项有效而有效的投资。成本效用数据正在处理中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号